Anti-atherogenic effects of CD36-targeted epigallocatechin gallate-loaded nanoparticles.
Zhang J, Nie S, Zu Y, Abbasi M, Cao J, Li C, Wu D, Labib S, Brackee G, Shen CL, Wang S.
Zhang J, et al. Among authors: wu d.
J Control Release. 2019 Jun 10;303:263-273. doi: 10.1016/j.jconrel.2019.04.018. Epub 2019 Apr 15.
J Control Release. 2019.
PMID: 30999008
Free PMC article.